Interestingly, LILRB1 expressing cells from 1 Sezary Syndrome patient were less susceptible to CD3/TCR-dependent activation-induced cell death [52], an anti-oncogenic role of TCR also noted in adult T-cell lymphoma patients [72]. The gene discussed is LILRB1; the disease is T-cell non-Hodgkin lymphoma.